article thumbnail

Will enterprises soon keep their best gen AI use cases under wraps?

CIO

As the technology exhausts its honeymoon period, and companies in all industries find new ways of using it to get ahead of the competition, a new race is on. The victors may not be the greatest innovators, but they’ll be the best at protecting their innovations.

Biotech 812
article thumbnail

CIO Guy Hadari on the management skills that set IT leaders apart

CIO

Most people consider the CIO to be a technology person, and they want to put them in a technology box, but technology should be only 20% of a CIO’s job,” says Hadari, who has been leading IT for the $15 billion biotech business since March 2021. Here are the essential management skills he looks for in IT leaders today.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The ‘Great Retraining’: IT upskills for the future

CIO

When the timing was right, Chavarin honed her skills to do training and coaching work and eventually got her first taste of technology as a member of Synchrony’s intelligent virtual assistant (IVA) team, writing human responses to the text-based questions posed to chatbots.

article thumbnail

BCG & Hello Tomorrow Track Innovation in Deep Tech Using NetBase Quid

Netbasequid

In their paper on Deep Tech: The Great Wave of Innovation , BCG and Hello Tomorrow explain “what deep tech is, how it works, how different stakeholders can contribute to it, and how it can be harnessed for competitive advantage.” How patent intel can reveal emerging innovations. From here, the biotech world is your oyster.

Biotech 98
article thumbnail

Key Takeaways from J.P. Morgan’s 41st Annual Healthcare Conference?

Alpha Sense BI

Attracting industry leaders, emerging fast-growth companies, and technology creators from around the world, life science corporations share their latest advances, leading research, and best practices — as well as their intentions to scale their digital health solutions — to the masses in hopes of securing capital.

Biotech 96
article thumbnail

Funding Insights May 8-14

Owler

Worldia’s product and the company’s resilience impressed investors like Credit Mutuel Innovation , who led the Series B funding round. Series A Funding Round Results in $59M for Taichu Biotech A China-based provider of drug development and evaluation services for the biopharmaceutical industry, Taichu Biotech raised $59M in funds.

Biotech 52
article thumbnail

Know where your competitors are conducting clinical trials!

Sedulo

Why did Chinese pharma companies conduct an overwhelming majority of their trials in China, whereas United States pharma companies conduct their trials spread across all listed countries?

Biotech 52